These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 856615)

  • 21. Structure-activity relationships for the competitive angiotensin antagonist [sarcosine,O-methyltyrosine4]angiotensin II (sarmesin).
    Goghari MH; Franklin KJ; Moore GJ
    J Med Chem; 1986 Jun; 29(6):1121-4. PubMed ID: 3754902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of induced aldosterone biosynthesis with a specific antagonist of angiotensin II.
    Chiu AT; Peach MJ
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):341-4. PubMed ID: 4360940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative receptor-binding properties of heptapeptide and octapeptide antagonists of angiotensin II in rat adrenal glomerulosa and uterine smooth muscle.
    Douglas JG; Michailov M; Khosla MC; Bumpus FM
    Endocrinology; 1980 Jan; 106(1):120-4. PubMed ID: 7349950
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of the pressor and aldosterone-releasing effects of angiotensin II.
    Bumpus FM; Khosla MC
    Clin Sci Mol Med Suppl; 1975 Jun; 2():15s-18s. PubMed ID: 1077765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal medullary stimulation induced by angiotensin I, angiotensin II, and analogues.
    Peach MJ
    Circ Res; 1971 May; 28(5):Suppl 2:107-17. PubMed ID: 4327959
    [No Abstract]   [Full Text] [Related]  

  • 26. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
    Saltman S; Baukal A; Waters S; Bumpus FM; Catt KJ
    Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of AT2 receptors at NRVL in tonic baroreflex suppression by endogenous angiotensins.
    Lin KS; Chan JY; Chan SH
    Am J Physiol; 1997 May; 272(5 Pt 2):H2204-10. PubMed ID: 9176287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin-angiotensin mediation of adrenal catecholamine secretion induced by hypoglycaemia in the cat.
    Bumpus MF; Feuerstein G; Gutman Y; Khosla MC
    Br J Pharmacol; 1980 Jun; 69(2):201-5. PubMed ID: 7002241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pressor action and dipsogenicity induced by angiotensin II and III in rats.
    Wright JW; Morseth SL; Abhold RH; Harding JW
    Am J Physiol; 1985 Nov; 249(5 Pt 2):R514-21. PubMed ID: 4061676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.
    Hawcock AB; Barnes JC; Michel AD
    Br J Pharmacol; 1992 Mar; 105(3):686-90. PubMed ID: 1628155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Des-Asp1] angiotensin II: mediator of the renin-angiotensin system?
    Freeman RH; Davis JO; Lohmeier TE; Spielman WS
    Fed Proc; 1977 Apr; 36(5):1766-70. PubMed ID: 321257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-angiotensin mediation of adrenal catecholamine secretion induced by haemorrhage.
    Feurerstein G; Boonyaviroj P; Gutman Y
    Eur J Pharmacol; 1977 Jul; 44(2):131-42. PubMed ID: 885164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation of angiotensin II agonist and antagonist analogues with 5,5-dimethylthiazolidine-4-carboxylic acid and other constrained amino acids.
    Samanen J; Cash T; Narindray D; Brandeis E; Adams W; Weideman H; Yellin T; Regoli D
    J Med Chem; 1991 Oct; 34(10):3036-43. PubMed ID: 1920354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Actions of somatostatin on perfused bovine adrenal glands and cultured bovine adrenal medullary cells.
    Moeller I; Bunn SJ; Marley PD
    Brain Res; 1989 Apr; 484(1-2):192-202. PubMed ID: 2565751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular Ca2+ antagonist TMB-8 blocks catecholamine secretion evoked by caffeine and acetylcholine from perfused cat adrenal glands in the absence of extracellular Ca2+.
    Yamada Y; Teraoka H; Nakazato Y; Ohga A
    Neurosci Lett; 1988 Aug; 90(3):338-42. PubMed ID: 3419642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonists.
    Chang RS; Lotti VJ; Chen TB; Faust KA
    Biochem Biophys Res Commun; 1990 Sep; 171(2):813-7. PubMed ID: 2403363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A potent noncompetitive angiotensin II antagonist induces only competitive inhibition of angiotensin III responses.
    Trachte GJ; Peach MJ
    J Cardiovasc Pharmacol; 1983; 5(6):1025-33. PubMed ID: 6196550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin II mediation of adrenal catecholamine secretion induced by intrarenal isoprenaline infusion.
    Feuerstein G; Krausz M; Cohen S; Gutman Y; Khosla MC; Bumpus MF
    Eur J Pharmacol; 1978 Dec; 52(3-4):375-7. PubMed ID: 729647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of angiotensin receptors in rat isolated uterus, portal vein, and aorta with the novel competitive antagonist sarmesin.
    Scanlon MN; Moore GJ
    Pharmacology; 1988; 37(3):137-47. PubMed ID: 3227047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of paired analogs of angiotensin II and angiotensin III on rat smooth muscle.
    Moore GJ; Ko EM
    Pharmacology; 1980; 20(1):36-41. PubMed ID: 7375500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.